Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
Abstract Background Pathological deposition of hyperphosphorylated tau in the brain closely correlates with the course of Alzheimer’s disease (AD). Tau pathology occurs in axons of affected neurons and tau removal from axons might thus be an early intervention strategy. Methods We investigated the r...
Saved in:
| Main Authors: | Abdolhossein Zare, Saeede Salehi, Jakob M. Bader, Anna-Lena Wiessler, Manuela Prokesch, Vincent Albrecht, Carmen Villmann, Matthias Mann, Michael Briese, Michael Sendtner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Translational Neurodegeneration |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40035-025-00499-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery and characterization of stereodefined PMO-gapmers targeting tau
by: Kunihiko Kanatsu, et al.
Published: (2025-03-01) -
Cholinergic‐associated loss of hnRNP‐A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice
by: Amit Berson, et al.
Published: (2012-05-01) -
[Letter to the Editor] Accelerated RNA—RNA hybridization by concentrated guanidinium thiocyanate solution in single-step RNA isolation
by: Triin Mölder, et al.
Published: (2016-08-01) -
Targeting WDPF domain of Hsp27 achieves a broad spectrum of antiviral
by: Mandi Wu, et al.
Published: (2025-03-01) -
Disruption of hnRNP A2-mediated RNA dynamics by amyloid-β drives MBP increase in Alzheimer’s disease
by: Adhara Gaminde-Blasco, et al.
Published: (2025-08-01)